Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Mesko

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Oncology|January 24, 2015
Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanomaLynn E Spitler, Peter Boasberg, Steven O'Day, et al.
American Journal of Clinical Oncology|June 10, 2016
Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk StratificationShane Mesko, Leonard Marks, Omar Ragab, et al.
Brachytherapy|November 13, 2017
Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 ccChenyang Wang, Jagdeep Raince, Uma Swamy, et al.
JCO Oncology Practice|June 7, 2021
Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for ImprovementDavid Boyce-Fappiano, Matthew S Ning, Olsi Gjyshi, et al.
Brachytherapy|April 9, 2014
Multiparametric MRI identifies and stratifies prostate cancer lesions: implications for targeting intraprostatic targetsErik S Anderson, Daniel J A Margolis, Shane Mesko, et al.
Brachytherapy|September 21, 2020
Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residentsShane Mesko, Bhavana V Chapman, Chad Tang, et al.
Cureus|July 30, 2019
Spine Stereotactic Radiosurgery for Metastatic PheochromocytomaShane Mesko, Brian J Deegan, Neil M D'Souza, et al.
Clinical Lung Cancer|July 31, 2020
Postoperative Radiotherapy for Locally Advanced NSCLC: Implications for Shifting to Conformal, High-Risk FieldsBhavana V Chapman, Matthew S Ning, Benjamin Farnia, et al.
JCO Oncology Practice|November 26, 2019
Time-Driven, Activity-Based Cost Analysis of Radiation Treatment Options for Spinal MetastasesDavid Boyce-Fappiano, Matthew S Ning, Nikhil G Thaker, et al.
Clinical and Translational Radiation Oncology|June 13, 2020
Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costingTodd A Pezzi, Matthew S Ning, Nikhil G Thaker, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|January 24, 2015
Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanomaLynn E Spitler, Peter Boasberg, Steven O'Day, et al.
American Journal of Clinical Oncology|June 10, 2016
Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk StratificationShane Mesko, Leonard Marks, Omar Ragab, et al.
Brachytherapy|November 13, 2017
Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 ccChenyang Wang, Jagdeep Raince, Uma Swamy, et al.
JCO Oncology Practice|June 7, 2021
Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for ImprovementDavid Boyce-Fappiano, Matthew S Ning, Olsi Gjyshi, et al.
Brachytherapy|April 9, 2014
Multiparametric MRI identifies and stratifies prostate cancer lesions: implications for targeting intraprostatic targetsErik S Anderson, Daniel J A Margolis, Shane Mesko, et al.
Brachytherapy|September 21, 2020
Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residentsShane Mesko, Bhavana V Chapman, Chad Tang, et al.
Cureus|July 30, 2019
Spine Stereotactic Radiosurgery for Metastatic PheochromocytomaShane Mesko, Brian J Deegan, Neil M D'Souza, et al.
Clinical Lung Cancer|July 31, 2020
Postoperative Radiotherapy for Locally Advanced NSCLC: Implications for Shifting to Conformal, High-Risk FieldsBhavana V Chapman, Matthew S Ning, Benjamin Farnia, et al.
JCO Oncology Practice|November 26, 2019
Time-Driven, Activity-Based Cost Analysis of Radiation Treatment Options for Spinal MetastasesDavid Boyce-Fappiano, Matthew S Ning, Nikhil G Thaker, et al.
Clinical and Translational Radiation Oncology|June 13, 2020
Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costingTodd A Pezzi, Matthew S Ning, Nikhil G Thaker, et al.
Pageof 3